BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PTCH1, RP11-435O5_3, Q13635, PTCH, 5727, HPE7, FLJ26746, NBCCS, BCNS, PTC1, ENSG00000185920, FLJ42602 AND Diagnosis
50 results:

  • 1. [Clinical significance of multigene assay in papillary thyroid carcinoma].
    Shi Y; Qian K; Guo K; Liu J; Wang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 37(5):375-379. PubMed ID: 37138401
    [No Abstract]    [Full Text] [Related]  

  • 2. Testing of mutations on thyroid nodules with indeterminate cytology: A prospective study of 112 patients in Argentina.
    Tolaba N; Spedalletti Y; Bazzoni P; Galindez M; Cerioni V; Santillan C; Richter G; Herrera C; Sanchez L; Van Cawulaert L; Toscano MA; Nallar M; Monteros Alvi M; Moya CM
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Feb; 69(2):122-130. PubMed ID: 35256055
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular profiling of papillary thyroid carcinomas in healthcare workers exposed to low dose radiation at the workplace.
    Duque CS; Vélez A; Cuartas J; Jaimes F; Dueñas JP; Agudelo M; Nikiforova MN; Nikiforov YE; Condello V
    Endocrine; 2022 Apr; 76(1):95-100. PubMed ID: 35094311
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ptch1-GLI1 Fusion-Positive Ovarian Tumor: Report of a Unique Case With Response to Tyrosine Kinase Inhibitor Pazopanib.
    Alwaqfi RR; Samuelson MI; Guseva NN; Ouyang M; Bossler AD; Ma D
    J Natl Compr Canc Netw; 2021 Sep; 19(9):998-1004. PubMed ID: 34551385
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Atypical de Quervain's thyroiditis diagnosed as atypia of undetermined significance by cytology and suspicious for cancer by Afirma Genomic Sequencing Classifier.
    Yu R; Yang SE; Rao J
    Diagn Cytopathol; 2021 Aug; 49(8):E312-E315. PubMed ID: 33656790
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Clinicopathological Results of Thyroid cancer With BRAFV600E Mutation in the Young Population of Fukushima.
    Iwadate M; Mitsutake N; Matsuse M; Fukushima T; Suzuki S; Matsumoto Y; Ookouchi C; Mizunuma H; Nakamura I; Nakano K; Sakamoto A; Hirokawa M; Ito M; Naganuma H; Hashimoto Y; Shimura H; Yamashita S; Suzuki S
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32827026
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
    Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
    Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients.
    Fulciniti F; Cipolletta Campanile A; Malzone MG; Chiofalo MG; Capiluongo A; Monaco M; Di Maio N; Sandomenico F; Botti G; Chiappetta G; Vuttariello E; Pezzullo L
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):851-859. PubMed ID: 31483883
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of potentially druggable molecular alterations in skin adnexal malignancies.
    Cavalieri S; Busico A; Capone I; Conca E; Dallera E; Quattrone P; Licitra L; Pruneri G; Bossi P; Perrone F
    J Dermatol; 2019 Jun; 46(6):507-514. PubMed ID: 31038235
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical impact of testing for mutations and microRNAs in thyroid nodules.
    Sistrunk JW; Shifrin A; Frager M; Bardales RH; Thomas J; Fishman N; Goldberg P; Guttler R; Grant E
    Diagn Cytopathol; 2019 Aug; 47(8):758-764. PubMed ID: 31013001
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma.
    Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL
    Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multiplex PCR approach to simultaneously identify several mutations in fine needle cytology thyroid samples.
    Vuttariello E; Borra M; Mauriello E; Calise C; D'Andrea B; Capiluongo A; Fulciniti F; Cipolletta A; Monaco M; Pezzullo L; Chiappetta G
    Oncotarget; 2017 Jul; 8(30):49351-49358. PubMed ID: 28537891
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hürthle Cells Adenoma of the Thyroid with Post-surgical Implants in the neck: Clinical, Morphological, and Molecular Analysis of Three Cases.
    Bongiovanni M; Uccella S; Giovanella L; Molinari F; Frattini M; Dionigi G; Piantanida E; Nobile A; Sessa F; La Rosa S
    Endocr Pathol; 2016 Dec; 27(4):338-345. PubMed ID: 27108352
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiation exposure, young age, and female gender are associated with high prevalence of RET/ptc1 and RET/PTC3 in papillary thyroid cancer: a meta-analysis.
    Su X; Li Z; He C; Chen W; Fu X; Yang A
    Oncotarget; 2016 Mar; 7(13):16716-30. PubMed ID: 26918339
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison.
    Giovanella L; Campenni A; Treglia G; Verburg FA; Trimboli P; Ceriani L; Bongiovanni M
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1018-26. PubMed ID: 26695504
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
    Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
    Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.
    Zhang L; Zhou Y; Cheng C; Cui H; Cheng L; Kong P; Wang J; Li Y; Chen W; Song B; Wang F; Jia Z; Li L; Li Y; Yang B; Liu J; Shi R; Bi Y; Zhang Y; Wang J; Zhao Z; Hu X; Yang J; Li H; Gao Z; Chen G; Huang X; Yang X; Wan S; Chen C; Li B; Tan Y; Chen L; He M; Xie S; Li X; Zhuang X; Wang M; Xia Z; Luo L; Ma J; Dong B; Zhao J; Song Y; Ou Y; Li E; Xu L; Wang J; Xi Y; Li G; Xu E; Liang J; Yang X; Guo J; Chen X; Zhang Y; Li Q; Liu L; Li Y; Zhang X; Yang H; Lin D; Cheng X; Guo Y; Wang J; Zhan Q; Cui Y
    Am J Hum Genet; 2015 Apr; 96(4):597-611. PubMed ID: 25839328
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer.
    Rossi M; Buratto M; Tagliati F; Rossi R; Lupo S; Trasforini G; Lanza G; Franceschetti P; Bruni S; Degli Uberti E; Zatelli MC
    Thyroid; 2015 Feb; 25(2):221-8. PubMed ID: 25333496
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile.
    Lubitz CC; Economopoulos KP; Pawlak AC; Lynch K; Dias-Santagata D; Faquin WC; Sadow PM
    Thyroid; 2014 Jun; 24(6):958-65. PubMed ID: 24417340
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Follicular-derived neoplasms: morphometric and genetic differences.
    Proietti A; Sartori C; Borrelli N; Giannini R; Materazzi G; Leocata P; Elisei R; Vitti P; Miccoli P; Basolo F
    J Endocrinol Invest; 2013 Dec; 36(11):1055-61. PubMed ID: 23888303
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.